Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca announces top-line results from phase III monotherapy study of lesinurad in gout patients
-
FDA Advisory Committee votes on investigational medicine metreleptin
-
FDA Advisory Committee recommends the investigational SGLT2 inhibitor dapagliflozin for treatment of type 2 diabetes in adults
-
AstraZeneca donates Brixham Environmental Laboratory to Plymouth University
-
European Commission approves Fluenz Tetra for the prevention of seasonal influenza in children
-
AstraZeneca awarded damages in Prilosec® patent litigation
-
Xigduo™ (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
-
New Drug Application for naloxegol accepted by United States Food and Drug Administration
-
AstraZeneca appoints architect for new global R&D centre and corporate headquarters in Cambridge, UK
-
AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex in Macclesfield
Latest articles and press releases
All of our latest press releases and articles are available to explore
